Laboratory Management & Operations

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

Pathomation and Mindpeak: Mindpeak’s CE-IVD certified algorithms are now fully integrated and operational within Pathomation’s trusted digital pathology platform, built for interoperability and control, enabling frictionless AI adoption in...

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...

"The main business of humanity is to do a good job of being human beings," said Paul, "not to serve as appendages to machines, institutions, and systems." If you have not read Player Piano, it is a good read. I read it many years ago...

As life sciences R&D teams increasingly leverage digital pathology and AI to accelerate their precision medicine programs, Proscia’s Concentriq LS platform is handling unprecedented volumes of high-resolution images, complex annotations,...

From the Lumea blog: Digital transformation is reshaping industries across the globe, and pathology is no exception. While much of the “dig path” buzz centers around the potential of artificial intelligence (AI) as a diagnostic aid,...